Provider's Clinical Support System - Medication Assisted Treatment Grant
The summary for the Provider's Clinical Support System - Medication Assisted Treatment Grant grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Substance Abuse and Mental Health Services Adminis, which is the U.S. government agency offering this grant.
Provider's Clinical Support System - Medication Assisted Treatment Grant: The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Treatment (CSAT) is accepting applications for fiscal year (FY) 2019 Provider's Clinical Support System - Medication Assisted Treatment (Short Title: PCSS-MAT) grant. The purpose of this program is to expand the number of Drug Addiction Treatment Act (DATA) 2000 waived providers, increase understanding of the importance of medication-assisted treatment and ultimately increase access to MAT through expanded prescribing of FDA-approved medications for the treatment of opioid use disorders. Although the current initiative has provided multiple trainings and mentoring support, there still remains a significant need to increase the number of healthcare providers to address the nation's lack of adequate access to care and treatment for opioid and other substance use disorders. The PCSS-MAT program will continue to provide up-to-date and evidence-based information to support the training of health professionals and to address the complex issues of addiction.
Federal Grant Title: | Provider's Clinical Support System - Medication Assisted Treatment Grant |
Federal Agency Name: | Substance Abuse and Mental Health Services Adminis (HHS-SAMHS-SAMHSA) |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | TI-19-005 |
Type of Funding: | Grant |
CFDA Numbers: | 93.243 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | February 26th, 2019 |
Original Application Deadline: | February 26th, 2019 |
Posted Date: | December 28th, 2018 |
Creation Date: | December 28th, 2018 |
Archive Date: | March 28th, 2019 |
Total Program Funding: | $2,000,000 |
Maximum Federal Grant Award: | $2,000,000 |
Minimum Federal Grant Award: | $0 |
Expected Number of Awards: | 1 |
Cost Sharing or Matching: | No |
Last Updated: | December 28th, 2018 |
- Applicants Eligible for this Grant
- Others (see text field entitled "Additional Information on Eligibility" for clarification.)
- Additional Information on Eligibility
- Eligibility is limited to the national professional medical organizations authorized by the Drug Addiction Treatment Act of 2000 (DATA) to carry out the training of providers desiring to prescribe and/or dispense FDA-approved schedule III medications for addictive disorders. These organizations are the American Society of Addiction Medicine (ASAM), the American Academy of Addiction Psychiatry (AAAP), the American Medical Association (AMA), the American Osteopathic Academy of Addiction Medicine (AOAAM), and the American Psychiatric Association (APA). Any of these entities may apply individually; they may also apply as a consortium comprised of all or several of the eligible organizations. If a consortium is formed for this purpose, a single organization in the consortium must be the legal applicant, the recipient of the award, and the entity legally responsible for satisfying the grant requirements. If a consortium submits an application, a written agreement must be included outlining the roles and responsibilities of each participating national professional medical organization. This agreement must be signed by an authorized official of each member of the consortium and included in Attachment 3 of the application, “Roles and Responsibilities of Participating National Professional Medical Organizations.” There is a serious public health issue involving the abuse, misuse, non-medical use and concomitant morbidity and mortality associated with the increased availability of opioids for the treatment of acute pain, chronic pain, and opioid-related addiction. While these medications are mainly obtained legally through prescriptions, SAMHSA surveys indicate significant amounts are obtained through theft and other forms of diversion. In addition, SAMHSA recognizes the difficulty in assessing patients for appropriate opioid prescribing and the limited training that physicians, psychiatrists, and dentists may receive during their formal, specialized training. Moreover, licensed physicians who have completed their formal training may lack adequate mentoring, continuing medical education, and other resources to evaluate patients and prescribe opioid analgesics appropriately. To address this public health problem in a timely manner, SAMHSA is limiting eligibility to these five organizations because they have extensive experience providing educational and other support services for addictive disorders to physicians and other substance abuse and healthcare professionals. As such, SAMHSA believes they are uniquely qualified to meet the requirements outlined in this announcement because they have the experience, infrastructure, and capacity in place to expeditiously begin program activities.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- Eileen Bermudez
Office of Financial Resources, Division of Grants Management
Substance Abuse and Mental Health Services Administration
(240) 276-1412
[email protected] - Similar Government Grants
- • National Anti-Drug Coalitions Training and Workforce Development Cooperative Agreement
- • Promoting the Integration of Primary and Behavioral Health Care: Collaborative Care Model
- • Promoting the Integration of Primary and Behavioral Health Care: States
- • GLS Campus Suicide Prevention Grant Program
- • Sober Truth on Preventing Underage Drinking Act Grants
- • Grants to Expand Substance Abuse Treatment Capacity in Targeted Areas of Need
- • State Adolescent Substance Abuse Treatment Coordination
- • Circles of Care III: Tribal Infrastructure Grants for Transforming Behavioral Health Servi...
- More Grants from the Substance Abuse and Mental Health Services Adminis
- • National Anti-Drug Coalitions Training and Workforce Development Cooperative Agreement
- • Promoting the Integration of Primary and Behavioral Health Care: Collaborative Care Model
- • Promoting the Integration of Primary and Behavioral Health Care: States